Profit warning as tough trading conditions hit listed biotech business
Sheffield-based biotech firm Benchmark said it faces "challenging conditions" in its global shrimp and Mediterranean seabass/bream markets.
The AIM-listed company, which specialises in aquaculture health, nutrition and genetics, has today released its quarter three trading update.
It said: "The company has continued to face challenging conditions in the global shrimp and Mediterranean seabass/bream markets, as outlined in its half year results in June 2019, which has impacted sales volumes in Advanced Nutrition.
"Addition... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...